NewsBenzingaAnthropic首席执行官Dario Amodei在X上发布:“今天,我们宣布由克劳德领导的发现了一种分子机器,我们怀疑它可能代表了一种新的基因编辑机制。它的确切功能、生物技术效用(如果有的话)或者意义的程度尚不清楚,但至少这项工作是我在攻读博士学位时会为之自豪的。这项工作大部分是由克劳德完成的,尽管并非完全是如此:我们的生命科学团队建议了一个广泛的研究领域…” Anthropic首席执行官Dario Amodei在X上发布:“今天,我们宣布由克劳德领导的发现了一种分子机器,我们怀疑它可能代表了一种新的基因编辑机制。它的确切功能、生物技术效用(如果有的话)或者意义的程度尚不清楚,但至少这项工作是我在攻读博士学位时会为之自豪的。这项工作大部分是由克劳德完成的,尽管并非完全是如此:我们的生命科学团队建议了一个广泛的研究领域…” Benzinga 2026.09.23 18:54 (GMT+0) Open on Benzinga Other news Stocks Fall as the 10-Year T-note Yield Soars to a 19-Year High VC firm Bessemer now has another $5.75B to invest in (what else?) AI A $1 Billion Reason to Buy On Holdings Stock Palantir Hires Ex-Labour Deputy Tom Watson as It Aims to Expand U.K. Operations REGENXBIO Says All Ongoing Patent Litigation Regarding Patents-In-Suit To Be Terminated With Prejudice; Agrees Not To Sue Sarepta Or Affiliates Over Existing Elevidys Or AAVrh74-Based Capsids NeoVolta Q4 EPS $(0.24) Misses $(0.09) Estimate, Sales $13.460K Miss $1.272M Estimate
REGENXBIO Says All Ongoing Patent Litigation Regarding Patents-In-Suit To Be Terminated With Prejudice; Agrees Not To Sue Sarepta Or Affiliates Over Existing Elevidys Or AAVrh74-Based Capsids